• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位 37 岁女性,患有肥厚型心肌病,合并使用双腔植入式心律转复除颤器,需要行经皮经腔静脉心脏电复律除颤器导线拔除术和多学科管理。

A 37-Year-Old Woman with Hypertrophic Cardiomyopathy with a Dual-Chamber Implantable Cardioverter-Defibrillator Requiring Percutaneous Transvenous Lead Extraction and Multidisciplinary Management.

机构信息

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Department of Surgery, Division of Cardiothoracic Surgery, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

Am J Case Rep. 2021 Oct 22;22:e932073. doi: 10.12659/AJCR.932073.

DOI:10.12659/AJCR.932073
PMID:34675166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546269/
Abstract

BACKGROUND Percutaneous transvenous lead extraction (TLE) of cardiac implantable electronic devices can be performed with a high success rate. However, TLE has its limitations and challenges. Recognizing the challenges at an early stage during the procedure is vital for appropriate patient management. We present a challenging case of implantable cardioverter-defibrillator (ICD) lead extraction in which we aborted TLE in favor of elective surgical extraction (SE). This potentially prevented a major catastrophic complication of vascular tear, which would have required an emergent thoracotomy. CASE REPORT A 37-year-old woman with history of hypertrophic cardiomyopathy had a primary prevention dual-chamber ICD implant in 2001 and underwent right ventricular ICD lead revision in 2009 due to lead fracture. In 2019, she was again found to have right ventricular ICD lead malfunction. TLE was attempted, but no meaningful progression could be made despite using multiple extraction tools. Therefore, TLE was aborted in favor of SE. During elective SE, significant adhesions were noted, and the innominate vein was completely avulsed during removal of the leads, requiring venous reconstruction by the vascular surgery team. After SE and vascular reconstruction, an epicardial ICD system was placed, and the patient had an uneventful postoperative recovery. CONCLUSIONS This case report highlights the limitations of TLE and the importance of recognizing them in a timely manner. In all challenging cases, conversion to elective SE should be considered to avoid potential injuries warranting emergent surgical repair.

摘要

背景

经皮经腔心脏植入式电子设备(CIED)的静脉内导线拔除术(TLE)可以达到很高的成功率。然而,TLE 存在其局限性和挑战。在手术过程中尽早识别这些挑战对于患者的适当管理至关重要。我们提出了一个具有挑战性的心脏复律除颤器(ICD)导线拔除病例,我们选择了择期外科提取(SE)而非 TLE。这可能避免了血管撕裂这一重大灾难性并发症,否则需要紧急开胸手术。

病例报告

一名 37 岁女性,有肥厚型心肌病病史,2001 年植入了原发性预防双腔 ICD,2009 年因导线断裂而进行了右心室 ICD 导线修订。2019 年,她再次发现右心室 ICD 导线功能异常。尝试了 TLE,但尽管使用了多种提取工具,仍无法取得明显进展。因此,TLE 被放弃,转而选择 SE。在择期 SE 期间,发现存在明显的粘连,在取出导线时无名静脉完全撕裂,需要血管外科团队进行静脉重建。SE 和血管重建后,放置了心外膜 ICD 系统,患者术后恢复顺利。

结论

本病例报告强调了 TLE 的局限性以及及时识别这些局限性的重要性。在所有具有挑战性的病例中,应考虑转换为择期 SE,以避免潜在的损伤,需要紧急手术修复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/e1d8ea1c70e5/amjcaserep-22-e932073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/1871ef3ce7c6/amjcaserep-22-e932073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/bbea2dff0066/amjcaserep-22-e932073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/e1d8ea1c70e5/amjcaserep-22-e932073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/1871ef3ce7c6/amjcaserep-22-e932073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/bbea2dff0066/amjcaserep-22-e932073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c440/8546269/e1d8ea1c70e5/amjcaserep-22-e932073-g003.jpg

相似文献

1
A 37-Year-Old Woman with Hypertrophic Cardiomyopathy with a Dual-Chamber Implantable Cardioverter-Defibrillator Requiring Percutaneous Transvenous Lead Extraction and Multidisciplinary Management.一位 37 岁女性,患有肥厚型心肌病,合并使用双腔植入式心律转复除颤器,需要行经皮经腔静脉心脏电复律除颤器导线拔除术和多学科管理。
Am J Case Rep. 2021 Oct 22;22:e932073. doi: 10.12659/AJCR.932073.
2
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.经皮心内膜下心导管取出术在咨询下进行——比较 Riata、Sprint Fidelis 和未召回的植入式心脏复律除颤器导线。
Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28.
3
Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.经静脉取出起搏器和植入式心脏复律除颤器导线的结果和所需工具比较:单一大容量中心经验的见解。
J Cardiovasc Electrophysiol. 2024 Jul;35(7):1382-1392. doi: 10.1111/jce.16294. Epub 2024 May 9.
4
Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience.单中心经验:经静脉取出单线圈与双线圈植入式心脏复律除颤器导线的有效性和安全性
Medicine (Baltimore). 2019 Jul;98(30):e16548. doi: 10.1097/MD.0000000000016548.
5
Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction.经静脉导线拔除术中因灾难性并发症而需要紧急手术或血管内介入治疗的患者的预后。
Heart Rhythm. 2014 Mar;11(3):419-25. doi: 10.1016/j.hrthm.2013.12.004. Epub 2013 Dec 4.
6
Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.10 年以上植入式心律转复除颤器导线的机械拔除:来自单一高容量中心的见解。
Europace. 2023 Mar 30;25(3):1100-1109. doi: 10.1093/europace/euac272.
7
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.植入式心脏转复除颤器导线的提取结果因制造商和型号系列而异。
Europace. 2023 Dec 6;25(12). doi: 10.1093/europace/euad345.
8
Multicenter experience with transvenous lead extraction in arrhythmogenic right ventricular cardiomyopathy (ARVC).致心律失常性右室心肌病(ARVC)经静脉导线拔除的多中心经验。
Pacing Clin Electrophysiol. 2013 Oct;36(10):1280-3. doi: 10.1111/pace.12197. Epub 2013 Jun 20.
9
Management of cardiac implantable electronic device infection using a complete interdisciplinary approach.采用完全跨学科方法管理心脏植入式电子设备感染。
Herzschrittmacherther Elektrophysiol. 2021 Mar;32(1):124-127. doi: 10.1007/s00399-020-00728-1. Epub 2020 Oct 23.
10
Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction.经静脉植入式心脏复律除颤器导线拔除术中纤维性黏连的主要预测因素。
Heart Rhythm. 2014 Dec;11(12):2196-201. doi: 10.1016/j.hrthm.2014.08.011. Epub 2014 Aug 8.

引用本文的文献

1
Discussing the Prognosis and Complications of Transvenous Lead Extraction in Patients With Cardiac Implantable Electronic Devices (CIED): A Systematic Review.探讨心脏植入式电子设备(CIED)患者经静脉导线拔除的预后和并发症:一项系统评价
Cureus. 2023 Sep 11;15(9):e45048. doi: 10.7759/cureus.45048. eCollection 2023 Sep.

本文引用的文献

1
Management of cardiac implantable electronic device infection using a complete interdisciplinary approach.采用完全跨学科方法管理心脏植入式电子设备感染。
Herzschrittmacherther Elektrophysiol. 2021 Mar;32(1):124-127. doi: 10.1007/s00399-020-00728-1. Epub 2020 Oct 23.
2
Transvenous Lead Extractions: Current Approaches and Future Trends.经静脉导线拔除:当前方法与未来趋势。
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.
3
Hybrid minimally invasive technique with the bidirectional rotational Evolution mechanical sheath for transvenous lead extraction: A collaboration between electrophysiologists and cardiac surgeons.
采用双向旋转式Evolution机械鞘管的混合微创技术用于经静脉导线拔除:电生理学家与心脏外科医生的合作。
J Arrhythm. 2018 Apr 30;34(3):329-332. doi: 10.1002/joa3.12064. eCollection 2018 Jun.
4
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS.2018年欧洲心律协会(EHRA)关于导线拔除的专家共识声明:临床科学研究和注册登记的定义、终点、研究试验设计及数据收集要求的建议:得到亚太心脏节律学会(APHRS)/美国心律学会(HRS)/拉丁美洲心脏节律学会(LAHRS)认可。
Europace. 2018 Jul 1;20(7):1217. doi: 10.1093/europace/euy050.
5
Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.经静脉导线拔除术围手术期并发症的发生率及预测因素:国家心血管数据注册中心的真实世界经验。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e004768. doi: 10.1161/CIRCEP.116.004768. Epub 2018 Feb 16.
6
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
7
Hybrid Minimally Invasive Approach for Transvenous Lead Extraction: A Feasible Technique in High-Risk Patients.经静脉导线拔除的混合微创方法:高危患者的一种可行技术
J Cardiovasc Electrophysiol. 2017 Apr;28(4):466-473. doi: 10.1111/jce.13164. Epub 2017 Feb 9.
8
Twenty-year experience of transvenous lead extraction at a single centre.单中心经静脉导线拔除术的20年经验。
Europace. 2014 Sep;16(9):1350-5. doi: 10.1093/europace/eut424. Epub 2014 Feb 19.
9
High-risk lead removal by planned sequential transvenous laser extraction and minimally invasive right thoracotomy.通过计划性序贯经静脉激光取出术和微创右胸切开术进行高风险铅取出。
J Cardiovasc Electrophysiol. 2014 Jun;25(6):617-21. doi: 10.1111/jce.12368. Epub 2014 Feb 13.
10
Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction.经静脉导线拔除术中因灾难性并发症而需要紧急手术或血管内介入治疗的患者的预后。
Heart Rhythm. 2014 Mar;11(3):419-25. doi: 10.1016/j.hrthm.2013.12.004. Epub 2013 Dec 4.